Pharma

Your Article Summary

See Latest Articles

Amgen Introduces Neulasta FIRST STEP Program
Hill & Knowlton, 06/29/09

Amgen initiated the Neulasta FIRST STEP Program to provide assistance to eligible low income commercially-insured chemotherapy patients who need help affording their Neulasta co-insurance or co-payment requirement. The Neulasta FIRST STEP Program is the first medical benefit co-pay card in oncology and Amgen's latest addition to its long-standing patient assistance programs designed to meet the unique needs of each patient to help cover the cost of Amgen's medicines.

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09

Myriad Genetics Acquires Exclusive Rights to Pancreatic Cancer Gene Patents From Johns Hopkins
Myriad, 10/16/09

Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09

See All of Research & Development